Close Menu
    Saudi SnapshotSaudi Snapshot
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Saudi SnapshotSaudi Snapshot
    Home » RevitaLash® Cosmetics Launches Global and Local Impact Initiative in the Fight Against Breast Cancer
    PR Newswire

    RevitaLash® Cosmetics Launches Global and Local Impact Initiative in the Fight Against Breast Cancer

    October 3, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    The Mission-Driven Lash & Brow Leader Continues Its Year-Round Breast Cancer Awareness Efforts 

    VENTURA, Calif., Oct. 3, 2023 /PRNewswire/ — RevitaLash® Cosmetics is proud to announce the company’s annual Pink mission to make an impact in the fight against breast cancer. This initiative aims to provide both global and local support to organizations dedicated to breast cancer treatment, research, and education.

    RevitaLash Cosmetics Logo

    RevitaLash® Cosmetics, renowned for its innovative lash, brow, and hair beautification products, has a heartfelt origin. It began with a gift from a husband, Dr. Michael Brinkenhoff, to his beloved wife during her battle with breast cancer. Today, the company remains committed to honoring the legacy of Dr. Brinkenhoff’s late wife and RevitaLash® Cosmetics Co-Founder, Gayle Brinkenhoff.

    In 2022, the brand donated $50,000 to giving partner City of Hope to fund breast cancer treatment, research, and nursing education in the underserved region of sub-Saharan Africa. This program has made a tangible difference in patient outcomes and was honored by the White House during an official event recognizing private sector businesses whose philanthropic endeavors are advancing cancer research in Africa. RevitaLash® Cosmetics is proud to continue its support this year for City of Hope’s Ethiopia Breast Cancer Initiative with a donation of $40,000.

    In addition to their global impact goals, RevitaLash® Cosmetics is doubling down on their commitment to the local communities where their partners operate. This year, the company will match contributions made by their international distribution partners to the local breast cancer charity of their choice. This program provides partners an opportunity to make a significant impact on breast cancer initiatives in their respective regions, and further RevitaLash® Cosmetics’ global support.

    “Through our Pink mission, we invite our global partners to create a lasting impact in the fight against breast cancer,” said Dariel Sidney, Vice President of Philanthropy and Gayle Brinkenhoff’s eldest daughter. “We are proud to support City of Hope’s Ethiopia Breast Cancer Initiative and to empower our distributors to make a difference in their local communities as well, driving positive change and improving lives of those affected by breast cancer worldwide.”

    This year from September 1st through October 31st, 2023, the brand’s award-winning products will be housed in celebratory pink sleeves to honor the cause. For every special-edition RevitaLash® Advanced (3.5mL/2.0mL), RevitaLash® Advanced Sensitive (2.0mL), and RevitaBrow® Advanced (3.0 mL) sold, the company will donate $2 to breast cancer charities around the globe, up to a maximum donation of $170,000.

    The limited-edition offerings are available in select spas, salons, and specialty retailers and online at revitalash.com, beginning September 1st.

    About RevitaLash® Cosmetics
    RevitaLash® Cosmetics is a worldwide leader in developing advanced lash, brow, and hair beautification products. Established in 2006, the collection includes award-winning RevitaLash® Advanced Eyelash Conditioner and RevitaBrow® Advanced Eyebrow Conditioner, and is available in physician’s offices, spas, salons, and specialty retailers across 70 countries. A supporter of non-profit breast cancer initiatives, RevitaLash® Cosmetics donates a portion of proceeds to research and education initiatives, giving back to the breast cancer community year-round, not just in October. For information visit www.revitalash.com.

    About City of Hope
    City of Hope is dedicated to making a difference in the lives of people with cancer, diabetes and other life-threatening illnesses. With locations in California, Arizona, Illinois, and Georgia, their team of more than 11,000 includes researchers, associates, scientists, doctors, nurses, allied health professionals, graduate students, fundraising specialists, marketing professionals, volunteers and support staff. All are united by their desire to find cures and save lives.

    Logo – https://mma.prnewswire.com/media/1216896/RevitaLash_Cosmetics_Logo.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/revitalash-cosmetics-launches-global-and-local-impact-initiative-in-the-fight-against-breast-cancer-301944945.html

    Related Posts

    AG.AL Crowned Esports World Cup 2026 Club Champion After Landmark Competition in Paris

    August 24, 2026

    Additional Information on the Ehrmann Family Increasing Its Equity Stake in Artprice by Artmarket as Part of Artprice’s “AI-First” Transformation

    August 23, 2026

    AG AL’s Gwen Snatches Esports World Cup Club Championship Glory In Unbelievable Trackmania Final

    August 23, 2026

    Reuters NEXT Gulf leadership summit to return with Abu Dhabi Department of Economic Development as exclusive host city partner for next three years

    August 21, 2026

    STARTRADER Launches XAUUSD247, Extending Gold CFD Access Across the Full Week

    August 21, 2026

    Hisense Unveils 2026 E8S ULED MiniLED TV Models with Exclusive Amazon Launch Deals

    August 21, 2026
    Editor's Picks

    Australian team finds new way to tackle triple-negative breast cancer

    August 22, 2026

    Australian researchers from Adelaide University and the Olivia Newton-John Cancer Research Institute have identified a novel molecular switch that drives the spread of aggressive tumors. Published in EMBO Molecular Medicine, the breakthrough study reveals that Australian researchers uncover a promising new way to tackle triple-negative breast cancer by restoring a critical regulatory molecule known as miR-342. The discovery opens new avenues to prevent life-threatening secondary cancers in organs such as the lungs and bones. Triple-negative breast cancer accounts for 10% to 15% of Australia’s approximately 21,000 annual breast cancer diagnoses but causes a disproportionate number of deaths. Lead investigators demonstrated that when miR-342 levels fall, a cancer-driving pathway called E2F becomes overactive, allowing dormant cancer cells to spread throughout the body and form dangerous secondary tumors. In pre-clinical models, scientists demonstrated that restoring miR-342 levels markedly reduced the spread of cancer cells to distant organs. Furthermore, researchers discovered that palbociclib, an existing CDK4/6 inhibitor drug currently approved for hormone receptor-positive breast cancers, significantly halted metastatic tumor growth in models exhibiting low miR-342 levels. The findings suggest measuring miR-342 levels could allow doctors to repurpose existing therapeutics to treat high-risk patients.

    Nearly 22,000 Pakistanis deported from Gulf over 4 months

    August 22, 2026

    Japan posts record July trade as imports outpace exports

    August 21, 2026

    DR Congo allocated 70,000 doses for Ebola outbreak

    August 21, 2026

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026

    Indonesia 6.1 earthquake rattles North Sumatra coast

    August 19, 2026

    DRC Ebola outbreak sets national death toll record

    August 17, 2026
    © 2026 Saudi Snapshot | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.